Home / Products / Genome-edited Cells / FURIN Knockout HEK293FT Cell Line

FURIN Knockout HEK293FT Cell Line

Cat. No. ARG0304
Product Type:

Genome-edited Cells

Tissue Source:

Kidney

In stock
Request a Quote

Short Description 🔒

The FURIN Knockout HEK293FT Cell Line is a CRISPR/Cas9-edited knockout model in the HEK293FT embryonic kidney host. FURIN encodes a calcium-dependent serine endoprotease that processes proproteins, including TGF-??, insulin receptor, and viral glycoproteins, by cleavage at consensus motifs. This loss-of-function line enables studies of substrate activation, signaling, and viral entry in a high-transfectability background. By disrupting FURIN-mediated cleavage, the model permits investigation of TGF-?? signaling, MT1-MMP-driven invasion, and receptor maturation. Researchers can apply western blotting, pseudoparticle entry, and luciferase reporter assays to define processing-dependent pathways, and produce non-cleavable recombinant proteins.

Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Genome-edited Cells
Tissue Source:
Kidney
Age:
Fetus
Sex of Donor:
Female
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

Host Cell:
HEK293FT
Gene Name:
FURIN
Gene Identifier:
NCBI Gene ID 5045
Gene Species:
Homo sapiens (Human)

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

The FURIN Knockout HEK293FT Cell Line is a CRISPR/Cas9-edited knockout cell line that eliminates FURIN function in the HEK293FT host. This loss-of-function model enables precise dissection of calcium-dependent serine endoprotease activity in a well-characterized cellular background, disrupting proprotein processing of substrates critical for growth factor signaling and viral infectivity.

The parental HEK293FT line is a highly transfectable, adenovirus 5-transformed human embryonic kidney derivative stably expressing SV40 large T antigen. Widely used for protein expression and viral vector production, its robust growth and manipulability make it an optimal host for knockout-based studies of post-translational processing.

FURIN encodes a trans-Golgi network-resident serine endoprotease that cleaves inactive proproteins at the consensus Arg-X-(Lys/Arg)-Arg motif. This processing step is essential for activation of pro-TGF-??, pro-IGF1R, pro-insulin receptor, and pro-??-NGF, as well as for maturation of MT1-MMP. FURIN expression is upregulated by TGF-??, HIF-1??, STAT6, and IL-13, and its trafficking relies on interaction with PACS-1. By priming viral spike proteins, FURIN facilitates viral entry. Consequently, its knockout impairs TGF-?? signaling, insulin receptor processing, and Notch1 activation, with downstream effects on proliferation, adhesion, and extracellular matrix dynamics.

In HEK293FT cells, removing FURIN activity blocks the constitutive activation of multiple growth factor pathways and compromises viral glycoprotein maturation. This knockout line is thus pertinent for distinguishing FURIN-dependent signaling events, especially given the host’s widespread application in pseudoparticle-based viral entry assays. Additionally, it permits production of non-cleavable recombinant proteins, supporting research into proteolytic regulation of biological activity.

Applications include western blot analysis of proprotein accumulation, RT-qPCR profiling of TGF-?? and insulin receptor-responsive genes, and viral pseudoparticle entry experiments. Immunofluorescence and flow cytometry can assess substrate localization and surface receptor processing, while luciferase reporters quantify signaling outputs. The line is also suited for cancer invasion studies, as MT1-MMP activation is abolished, and for bioproduction of uncleaved protein variants. For further details, please contact Ascent Research.